Johann Meunier
Montpellier, 34095, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation.
Journal: ACS chemical neuroscience
Published: January 27, 2026
Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse model.
Journal: European journal of medicinal chemistry
Published: October 21, 2025
Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 08, 2025
Positive modulation of sigma-1 receptor: a new weapon to mitigate disease progression in amyotrophic lateral sclerosis.
Journal: Translational neurodegeneration
Published: May 12, 2025
Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ 1 chaperone protein.
Journal: Acta pharmaceutica Sinica. B
Published: March 19, 2024
Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties.
Journal: Phytotherapy research : PTR
Published: August 02, 2023
Restorative effects of probiotics on memory impairment in sleep-deprived mice.
Journal: Nutritional neuroscience
Published: March 03, 2022
Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer's Disease.
Journal: Frontiers in neuroscience
Published: March 23, 2020
In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models.
Journal: CNS & neurological disorders drug targets
Published: January 16, 2020
Strain specific stress-modulating effects of candidate probiotics: A systematic screening in a mouse model of chronic restraint stress.
Journal: Behavioural brain research
Published: August 16, 2019
Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: June 30, 2018
N-acetylcysteine Treatment Reduces Age-related Hearing Loss and Memory Impairment in the Senescence-Accelerated Prone 8 (SAMP8) Mouse Model.
Journal: Aging and disease
Published: August 17, 2017
Last Updated: 09/26/2026